Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,061,887 papers from all fields of science
Search
Sign In
Create Free Account
rivoglitazone
An agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic activity.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Thiazolidinediones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.
S. Kanda
,
Ryutaro Nakashima
,
+6 authors
J. Ohsumi
Journal of Pharmacological Sciences
2009
Corpus ID: 26373707
The pharmacological effects of rivoglitazone, a novel thiazolidinedione-derivative peroxisome proliferator-activated receptor…
Expand
2008
2008
Model‐Based Development of a PPARγ Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs
S. Rohatagi
,
T. Carrothers
,
+5 authors
D. Salazar
Journal of clinical pharmacology
2008
Corpus ID: 22932550
A model‐based approach was implemented for the development of the proliferator‐activated receptor gamma (PPARγ) agonist…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE